Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

42
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
42
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

34
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
34
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

48
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
48
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

22
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

139
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
139

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Adipose Tissue Memory and Why Patients Regain Weight after Weight Loss: Understanding the Immunologic Basis for Recurrent Cardiovascular Risk.

Cardiology in review·2026
Same author

Nonocclusive Mesenteric Ischemia in Cardiogenic Shock: Mechanisms of Splanchnic Hypoperfusion and Strategies for Early Detection.

Cardiology in review·2026
Same author

Understanding Dysfunctional Autophagy and Mitophagy in Inflammatory Cardiovascular Disease.

Cardiology in review·2026
Same author

The Cardiopulmonary Complications of Vaping.

Cardiology in review·2026
Same author

Transplant Allograft Markers of Rejection for Heart, Liver, and Kidney Transplantation: A Review.

Cardiology in review·2026
Same author

Metformin as a Cardioprotective Agent: New Life for an Old Drug?

Cardiology in review·2026
Same journal

Implementation Gaps and Limitations of Statin Therapy in Young Adults: Bridging Guideline Recommendations and Real-World Practice.

Cardiology in review·2026
Same journal

Cardiovascular Manifestations of Epilepsy.

Cardiology in review·2026
Same journal

Finerenone and Cardiorenal Outcomes: A Narrative Review.

Cardiology in review·2026
Same journal

Role of Polypeptide Procalcitonin in Cardiac and Microvascular Injury in Sepsis, Myocardial Ischemia/Reperfusion, Cardiac Arrest, Mixed Shock, and Stress.

Cardiology in review·2026
Same journal

Do Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Predict In-Hospital and Long-Term Mortality in Endocarditis Patients?: A Systematic Review and Meta-Analysis.

Cardiology in review·2026
Same journal

Pacing for Pressure: The Clinical Efficacy of AVIM Therapy in Hypertension Management.

Cardiology in review·2026
查看所有相关文章

相关实验视频

Updated: Sep 13, 2025

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

16.5K

心脏内:一个全面的审查.

Julia S Szinte1, Manish A Parikh1,2, William H Frishman3

  • 1From the Department of Medicine, New York Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY.

Cardiology in review
|August 4, 2025
PubMed
概括
此摘要是机器生成的。

心脏衰竭的严重症状 - - 心脏衰竭经常被忽视,但死亡率很高. 及时诊断和了解其复杂的原因对于有效治疗至关重要.

关键词:
脆弱性 脆弱性 脆弱性在IGF-1的基础上,IGF-1这就是RAAS RAAS.SGLT-2 抑制剂的使用.贫血 贫血 是一种疾病.贝塔抑制剂 贝塔抑制剂心脏缓解症的心脏缓解症充血性心力衰竭是一种射出分数的射出分数炎症性细胞因子是炎症性细胞因子.左心室辅助器件的使用方法有活性氧物种的反应性氧物种.这种类型的麻症是sarcopenia.

更多相关视频

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

11.8K
Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

846

相关实验视频

Last Updated: Sep 13, 2025

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

16.5K
Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

11.8K
Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

846

科学领域:

  • 心脏病学 心脏病学
  • 内部医学 内部医学
  • 病理生理学 病理生理学

背景情况:

  • 心脏缓冲症是一种复杂的综合征,影响患有晚期心力衰竭 (纽约心脏协会III-IV类) 的患者.
  • 它经常被误诊为衰老,导致延迟干预.
  • 这种疾病的死亡率在诊断后18个月内达到50%.

研究的目的:

  • 为了提供心脏缓冲症的全面分析.
  • 审查其定义,诊断标准,流行率和死亡率.
  • 探索病理生理学,可逆性和治疗选择.

主要方法:

  • 文献综述和对心脏缓存症现有研究的分析.
  • 检查病理生理机制,包括细胞因子释放,神经激素激活,肠道干预和缺铁性贫血.
  • 与肉症和脆弱性进行比较.

主要成果:

  • 心脏缓解症的特点是复杂的病理生理学,包括系统性炎症和肠道功能障碍.
  • 生物标志物,神经激素激活和缺铁性贫血是关键组成部分.
  • 为了准确的诊断,区分它与缩症和脆弱性至关重要.

结论:

  • 在心力衰竭患者中,心脏缓解症是未被认可和未得到治疗的.
  • 及时诊断和了解其多方面的病理生理学至关重要.
  • 对有效的药理和非药理治疗的进一步研究是有必要的.